Dexamethasone acts as a radiosensitizer in three astrocytoma cell lines via oxidative stress

Autor: Sylvia Ortega-Martínez
Přispěvatelé: Ministerio de Educación y Cultura (España), University of Washington, Oxford University Museum of Natural History, Ministerio de Ciencia e Innovación (España)
Rok vydání: 2015
Předmět:
Pathology
Radiation-Sensitizing Agents
DNA Repair
Clinical Biochemistry
GCs
glucocorticoids

Apoptosis
medicine.disease_cause
DNA damage response
Biochemistry
Dexamethasone
Histones
Radiation
Ionizing

Medicine
DEXA
dexamethasone

lcsh:QH301-705.5
lcsh:R5-920
Intracellular Signaling Peptides and Proteins
Cell cycle
musculoskeletal system
DDR
DNA Damage response

Comet Assay
lcsh:Medicine (General)
Tumor Suppressor p53-Binding Protein 1
Research Paper
musculoskeletal diseases
Programmed cell death
Radiosensitizer
medicine.medical_specialty
DNA repair
DNA damage
MR
mineralocorticoid receptor

Astrocytoma
Time-Lapse Imaging
Cell Line
Tumor

IR
Irradiation

Humans
Radiosensitivity
Glucocorticoids
GR
glucocorticoid receptor

business.industry
Organic Chemistry
Cell Cycle Checkpoints
Ascorbic acid
NHEJ
non-homologous end-joining pathway

Oxidative Stress
lcsh:Biology (General)
Microscopy
Fluorescence

DSBs
double strand breaks

Cancer research
business
Oxidative stress
Astrocytomas
Zdroj: Redox Biology
Redox Biology, Vol 5, Iss, Pp 388-397 (2015)
Digital.CSIC. Repositorio Institucional del CSIC
instname
ISSN: 2213-2317
DOI: 10.1016/j.redox.2015.06.006
Popis: Glucocorticoids (GCs), which act on stress pathways, are well-established in the co-treatment of different kinds of tumors; however, the underlying mechanisms by which GCs act are not yet well elucidated. As such, this work investigates the role of glucocorticoids, specifically dexamethasone (DEXA), in the processes referred to as DNA damage and DNA damage response (DDR), establishing a new approach in three astrocytomas cell lines (CT2A, APP.PS1 L.1 and APP.PS1 L.3). The results show that DEXA administration increased the basal levels of gamma-H2AX foci, keeping them higher 4 h after irradiation (IR) of the cells, compared to untreated cells. This means that DEXA might cause increased radiosensitivity in these cell lines. On the other hand, DEXA did not have an apparent effect on the formation and disappearance of the 53BP1 foci. Furthermore, it was found that DEXA administered 2 h before IR led to a radical change in DNA repair kinetics, even DEXA does not affect cell cycle. It is important to highlight that DEXA produced cell death in these cell lines compared to untreated cells. Finally and most important, the high levels of gamma-H2AX could be reversed by administration of ascorbic acid, a potent blocker of reactive oxygen species, suggesting that DEXA acts by causing DNA damage via oxidative stress. These exiting findings suggest that DEXA might promote radiosensitivity in brain tumors, specifically in astrocytoma-like tumors.
Graphical abstract
Highlights ● Dexamethasone causes DNA damage by increasing gamma-H2AX levels in three astrocytoma cell lines (CT2A, APP.PS1 L.1 and APP.PS1 L.3) ● Dexamethasone affects DNA repair kinetics and produces cell death in three astrocytoma cell lines (CT2A, APP.PS1 L.1 and APP.PS1 L.3) even dexamethasone does not affect any cell cycle arrest in any cell line studied. ● Oxidative stress appears to be one of the mechanisms of dexamethasone action in DNA damage as their effect is reversed with ascorbic acid addition.
Databáze: OpenAIRE